“State stem cell agency is taking Institutes of Medicine advice”
| The 306-word editorial said CIRM Chairman Jonathan Thomas is a refreshing change from Robert Klein, the first chairman of the $3 billion enterprise. The brief editorial said Thomas recognizes that the eight-year-old agency "has to mature." It said Thomas was trying to improve transparency and accountability. The last paragraph declared, “If the stem cell agency can establish a record as a good steward of public dollars to finance brilliant science, it can continue to play a useful role in stimulating and guiding research to bring the potential cures from stem cell research to fruition.” |
No comments:
Post a Comment